Shawn Cross
CIK 1734779 · Chief Financial Officer · last filed 2026-04-24
Shawn Cross is a Chief Financial Officer who has filed 34 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for PCRX, was dated Apr 24, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.57M
3
34
-$1.90M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Financial Officer | 105,341 | $24.43 | $2.57M | -$1.52M | 7 | 2026-04-24 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Director | 136,346 | $0.03 | $4.4K | $0 | 5 | 2025-03-03 |
| Applied Molecular Transport Inc. (AMTI) Delisted | CEO & Chair of the Board | 0 | $0.26 | $0 | -$383.5K | 15 | 2023-12-28 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-24 | PCRX | Mixed | — | -$112.7K | EDGAR |
| 2026-04-23 | PCRX | Notice (144) | −12,941 | -$325.6K | EDGAR |
| 2026-04-22 | PCRX | Notice (144) | −1,500 | -$37.5K | EDGAR |
| 2026-04-22 | PCRX | Mixed | — | -$104.2K | EDGAR |
| 2026-04-21 | PCRX | Notice (144) | −2,845 | -$71.1K | EDGAR |
| 2026-04-20 | PCRX | Notice (144) | −7,714 | -$193.9K | EDGAR |
| 2026-02-13 | PCRX | Grant (A) | +49,091 | $0 | EDGAR |
| 2025-12-11 | PCRX | Mixed | — | -$215.5K | EDGAR |
| 2025-12-10 | PCRX | Notice (144) | −9,104 | -$228.9K | EDGAR |
| 2025-12-09 | PCRX | Notice (144) | −15,896 | -$397.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.